An article authored by Dr Julie Warner, Vice President of Regulatory Affairs, has been featured by Drug Discovery World – the multi-platform global voice for the drug discovery community.
The article, titled: ‘Regulatory affairs in 2023: key trends and changes’ provides expert insight into the key regulatory developments likely to shape the global drug development industry this year.
Dr Julie Warner is Vice President of Regulatory Affairs and leads the award-winning regulatory team, supporting clients across the globe.
Read the full article on Drug Discovery World here.
To find out more about Boyds’ expert regulatory affairs services, get in touch.
